USANA
August 4, 2026
SALT LAKE CITY, Utah -- August 4, 2026
USANA Health Sciences reported second-quarter 2026 net sales of 223 million dollars, down 5% from 236 million dollars a year earlier. The company posted a net loss of 21.4 million dollars, or 1.16 dollars per diluted share, which included an estimated preliminary non-cash impairment charge of 29.1 million dollars, compared with net earnings of 9.7 million dollars, or 0.52 dollars per diluted share, a year earlier.
Adjusted diluted EPS was a loss of 0.07 dollars, and adjusted EBITDA was 27.8 million dollars versus 30.5 million dollars. Core Nutritional Active Customers were 384,000, down from 418,000.
USANA said foreign currency provided a favorable sales impact of about 6 million dollars, or 3%, in the quarter.